IGC PHARMA INC (IGC) Stock Price & Overview

NYSEARCA:IGC • US45408X3089

Current stock price

0.3101 USD
+0.01 (+4.41%)
At close:
0.3133 USD
+0 (+1.03%)
Pre-Market:

The current stock price of IGC is 0.3101 USD. Today IGC is up by 4.41%. In the past month the price increased by 10.87%. In the past year, price increased by 9.31%.

IGC Key Statistics

52-Week Range0.242 - 0.4985
Current IGC stock price positioned within its 52-week range.
1-Month Range0.25 - 0.32
Current IGC stock price positioned within its 1-month range.
Market Cap
28.799M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.08
Dividend Yield
N/A

IGC Stock Performance

Today
+4.41%
1 Week
+14.64%
1 Month
+10.87%
3 Months
+4.66%
Longer-term
6 Months -22.36%
1 Year +9.31%
2 Years -42.79%
3 Years -10.12%
5 Years -80.62%
10 Years +63.21%

IGC Stock Chart

IGC PHARMA INC / IGC Daily stock chart

IGC Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to IGC. When comparing the yearly performance of all stocks, IGC turns out to be only a medium performer in the overall market: it outperformed 50.01% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IGC Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to IGC. IGC may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IGC Earnings

Next Earnings DateJun 25, 2026
Last Earnings DateMar 2, 2026
PeriodQ2 / 2026
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise -26.70%

IGC Forecast & Estimates

6 analysts have analysed IGC and the average price target is 4.08 USD. This implies a price increase of 1215.7% is expected in the next year compared to the current price of 0.3101.

For the next year, analysts expect an EPS growth of 7.95% and a revenue growth -11.13% for IGC


Analysts
Analysts80
Price Target4.08 (1215.7%)
EPS Next Y7.95%
Revenue Next Year-11.13%

IGC Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

IGC Financial Highlights

Over the last trailing twelve months IGC reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS increased by 58.49% compared to the year before.


Income Statements
Revenue(TTM)1.11M
Net Income(TTM)-6.45M
Industry RankSector Rank
PM (TTM) N/A
ROA -66.16%
ROE -79.66%
Debt/Equity 0.02
Chartmill High Growth Momentum
EPS Q2Q%11.06%
Sales Q2Q%-53.64%
EPS 1Y (TTM)58.49%
Revenue 1Y (TTM)-6.51%

IGC Ownership

Ownership
Inst Owners20.11%
Shares92.87M
Float85.23M
Ins Owners3.92%
Short Float %0.87%
Short Ratio2.06

About IGC

Company Profile

IGC logo image The company is headquartered in Potomac, Maryland and currently employs 70 full-time employees. The company went IPO on 2006-04-13.

Company Info

IPO: 2006-04-13

IGC PHARMA INC

10224 Falls Road

Potomac MARYLAND 20854 US

CEO: Ram Mukunda

Employees: 70

IGC Company Website

IGC Investor Relations

Phone: 13015294996

IGC PHARMA INC / IGC FAQ

What does IGC do?

The company is headquartered in Potomac, Maryland and currently employs 70 full-time employees. The company went IPO on 2006-04-13.


What is the stock price of IGC PHARMA INC today?

The current stock price of IGC is 0.3101 USD. The price increased by 4.41% in the last trading session.


Does IGC stock pay dividends?

IGC does not pay a dividend.


What is the ChartMill rating of IGC PHARMA INC stock?

IGC has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What is the market capitalization of IGC stock?

IGC PHARMA INC (IGC) has a market capitalization of 28.80M USD. This makes IGC a Nano Cap stock.


What is the next earnings date for IGC stock?

IGC PHARMA INC (IGC) will report earnings on 2026-06-25.


Can you provide the short interest for IGC stock?

The outstanding short interest for IGC PHARMA INC (IGC) is 0.87% of its float.